MESO-Rx
Anabolic Steroids
albuterol.
- Thread starter dodah
- Start date
The albuterol will have no effect because your bronchials are not constricted. Once the anabolic was introduced into the bloodstream it went to the heart then directly into your lungs. The reason why you expirienced shortness of breath/difficulty beathing was because there was a small amount of fluid accumulation in the lungs. Your body's natural reaction to eliminate foreign the substance would be to cough. I've expirienced several episodes where I was too close to a vein and a minimal amount was absorbed into the bloodstream(yes, I aspirate). I would start to cough almost uncontrolled, usually on inspiration, but after a couple minutes it would pass. From then on, even after I aspirate, I will inject a very minimal amout then wait a couple seconds to see if I have that reaction. If I don't I'll finish my injection. If I do start to cough then I know I'll have to rejab.
Med Sci Sports Exerc. 2000 Jul;32(7):1300-6. Related Articles, Links
Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men.
van Baak MA, Mayer LH, Kempinski RE, Hartgens F.
Department of Human Biology, Maastricht University, The Netherlands. m.vanbaak@hb.unimaas.nL
PURPOSE: The ergogenic effect of acute beta2-adrenergic agonist administration in nonasthmatic individuals has not been clearly demonstrated. Therefore, the acute effects of oral administration of the beta2-adrenergic agonist salbutamol (4 mg) on muscle strength and endurance performance were studied in 16 nonasthmatic men in a double-blind randomized cross-over study. METHODS: Peak expiratory flow (Mini Wright Peakflowmeter), isokinetic strength of the knee extensors and knee flexors at four angular velocities (Cybex II dynamometer), and endurance performance in a cycle ergometer test until exhaustion at 70% of maximal workload were measured. RESULTs: Peak expiratory flow increased from 601 +/- 67 L x min(-1) to 629 +/- 64 L x min(-1) after salbutamol (P < 0.05). Peak torque was higher after salbutamol than after placebo (4.4% for the knee extensors, 4.9% for the knee flexors) (P < 0.05). Mean endurance time increased from 3,039 +/- 1,031 s after placebo to 3,439 +/- 1,287 s after salbutamol (P = 0.19). When four subjects complaining about adverse side effects were excluded from the analysis, the increase in endurance time (729 +/- 1,007 s or 29%) was statistically significant (P <-0.05). Salbutamol did not affect VO2, respiratory exchange ratio, heart rate, and plasma free fatty acid and glycerol concentration during exercise; plasma lactate and potassium concentrations were increased (P < 0.05). CONCLUSIONS: Under the conditions of this study, oral salbutamol appears to be an effective ergogenic aid in nonasthmatic individuals not experiencing adverse side effects.
Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men.
van Baak MA, Mayer LH, Kempinski RE, Hartgens F.
Department of Human Biology, Maastricht University, The Netherlands. m.vanbaak@hb.unimaas.nL
PURPOSE: The ergogenic effect of acute beta2-adrenergic agonist administration in nonasthmatic individuals has not been clearly demonstrated. Therefore, the acute effects of oral administration of the beta2-adrenergic agonist salbutamol (4 mg) on muscle strength and endurance performance were studied in 16 nonasthmatic men in a double-blind randomized cross-over study. METHODS: Peak expiratory flow (Mini Wright Peakflowmeter), isokinetic strength of the knee extensors and knee flexors at four angular velocities (Cybex II dynamometer), and endurance performance in a cycle ergometer test until exhaustion at 70% of maximal workload were measured. RESULTs: Peak expiratory flow increased from 601 +/- 67 L x min(-1) to 629 +/- 64 L x min(-1) after salbutamol (P < 0.05). Peak torque was higher after salbutamol than after placebo (4.4% for the knee extensors, 4.9% for the knee flexors) (P < 0.05). Mean endurance time increased from 3,039 +/- 1,031 s after placebo to 3,439 +/- 1,287 s after salbutamol (P = 0.19). When four subjects complaining about adverse side effects were excluded from the analysis, the increase in endurance time (729 +/- 1,007 s or 29%) was statistically significant (P <-0.05). Salbutamol did not affect VO2, respiratory exchange ratio, heart rate, and plasma free fatty acid and glycerol concentration during exercise; plasma lactate and potassium concentrations were increased (P < 0.05). CONCLUSIONS: Under the conditions of this study, oral salbutamol appears to be an effective ergogenic aid in nonasthmatic individuals not experiencing adverse side effects.
mr_meanor said:
